48-50 In 1999, the guidelines for the performance of a comprehensive intraoperative multiplane TEE Z-VAD-FMK cell line examination were published by the American Society
of Echocardiography and Society of Cardiovascular Anesthesiologists.51 Currently, intra-operative TEE (IOTEE) is requested for all patients undergoing all valve repair, patients with aortic valve disease requiring valve replacement (for evaluation of mitral regurgitation), myomectomy in patients with hypertrophic cardiomyopathy (HCM), cardiac mass removal, repair of intracardiac shunts including atrial and ventricular Inhibitors,research,lifescience,medical septal defects, and all patients with congenital heart disease.41,42 Contrast Echocardiography There are several clinical implications for contrast echocardiography. Inhibitors,research,lifescience,medical It is especially useful for evaluating intracardiac shunts.52 Initially, it was done by injecting agitated saline through a peripheral vein. But inability to control the intensity of the contrast effect was the major problem of this technique. This problem was solved by the development of stable contrast agents that were suitable for opacifying the Inhibitors,research,lifescience,medical right-sided cardiac chambers and evaluating
the intracardiac shunts.53 Subsequently, several studies,53,54 showed that intravenous left heart contrast agents improve left ventricular endocardial border definition, besides the image quality in patients with poor image views (figure 3). In ischemic heart disease, myocardial perfusion could be investigated using Inhibitors,research,lifescience,medical intravenous contrast agents. Figure 3 This figure shows contrast echocardiography in a patient with poor
image quality (upper panel) showed marked apical hypertrophy and spade-like LV cavity (lower panel). Epicardial Echocardiography Sometimes TEE images may be suboptimal or there may be contraindications to TEE. By placing a high frequency ultrasound probe in a sterile sheath, the heart can be imaged from the epicardial surface. Three-Dimensional Echocardiography The idea of three-dimensional Inhibitors,research,lifescience,medical (3D) echocardiography began to develop in the 1960s. However, the first three-dimensional scans of the heart were reported in 1974.55 The earliest 3D echocardiograms were obtained using the reconstruction technique.47,56 With this technique ECG gated images are obtained from varying transducer locations of definite position. Using different software programs, each image is aminophylline located into its proper three dimensional spatial positions in cardiac cycle; and then using specific image processing techniques the structure can be reconstructed as a 3D object. Then the surfaces and volumes are displayed. Developing complex transthoracic transducer enabled us to acquit 3D volume data sets in real time or near real time. The 3D technique has changed rapidly, and currently different types of real-time 3D imaging are available. In current real-time 3D systems, matrix array transducers with 3000-4000 elements have been used.